Related Experiment Videos
[Hyperlipidemia in liver transplanted patients]
C Fernández-Miranda1, A De la Calle, C Loinaz
1Servicio de Medicina Interna, Hospital Universitario "12 de Octubre", Madrid, 28041, España.
Insights
Hyperlipemia is common after liver transplantation, linked to various health issues and immunosuppressants. Managing cholesterol is crucial for liver transplant recipients to prevent cardiovascular disease.
Area of Science:
- Nephrology
- Endocrinology
- Cardiology
Context:
- Hyperlipemia frequently occurs in liver transplant recipients.
- Associated factors include cholestasis, renal insufficiency, obesity, and diabetes.
- Immunosuppressant therapy is a significant contributor.
Purpose:
- To discuss the management of hyperlipemia in liver transplant patients.
- To highlight the importance of cholesterol control for cardiovascular health.
- To review safe and effective treatment options.
Summary:
- Post-liver transplant hyperlipemia is linked to several comorbidities and immunosuppression.
- While direct links to cardiovascular disease are unproven, cholesterol management is advised.
- Treatment involves lifestyle changes, minimizing cyclosporine, discontinuing corticoids, and considering statins like Lovastatin and Pravastatin.
Impact:
- Emphasizes the need for proactive cholesterol management in liver transplant recipients.
- Provides guidance on optimizing immunosuppression and medication choices.
- Aims to reduce cardiovascular disease risk in this vulnerable population.
Abstract:
Hyperlipemia is frequent in liver transplanted patients and has been related with the existence of cholestasis, renal insufficiency, obesity, diabetes, and especially with immunosuppressant treatment. Although there are no studies that show a relationship between post-liver transplant hyperlipemia and the development of cardiovascular disease, there are data that indicate that liver transplanted patients should control their cholesterol levels to reduce the incidence of this disease. When post-transplant hyperlipemia is present, hygienic-dietary measures should be established and treatment should be carried out with the minimum dose of cyclosporine needed to maintain the graft stable. Corticoids should be discontinued as soon as possible. Treatment with some statins (Lovastatin and Pravastatin) has shown to be safe and efficacy in the liver transplanted patients with hypercholesterolemia.